NDC 0054-4581

Mercaptopurine

Mercaptopurine

Mercaptopurine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Mercaptopurine.

Product ID0054-4581_0af63ac3-f9e8-4cba-8bb0-b42cec662c80
NDC0054-4581
Product TypeHuman Prescription Drug
Proprietary NameMercaptopurine
Generic NameMercaptopurine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2004-02-13
Marketing CategoryANDA / ANDA
Application NumberANDA040528
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameMERCAPTOPURINE
Active Ingredient Strength50 mg/1
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0054-4581-11

25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11)
Marketing Start Date2004-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0054-4581-11 [00054458111]

Mercaptopurine TABLET
Marketing CategoryANDA
Application NumberANDA040528
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-02-13

NDC 0054-4581-27 [00054458127]

Mercaptopurine TABLET
Marketing CategoryANDA
Application NumberANDA040528
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-02-13

Drug Details

Active Ingredients

IngredientStrength
MERCAPTOPURINE50 mg/1

OpenFDA Data

SPL SET ID:c3b5b8b0-bc5c-4ce9-bbdc-febba60c2658
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197931
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]
    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Mercaptopurine" or generic name "Mercaptopurine"

    NDCBrand NameGeneric Name
    0054-4581MercaptopurineMercaptopurine
    0378-3547Mercaptopurinemercaptopurine
    49884-922mercaptopurinemercaptopurine
    69076-913MercaptopurineMercaptopurine
    60763-601PURINETHOLMercaptopurine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.